---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-102659"
form_type: "8-K"
ticker: "EMED"
cik: "0001715819"
company_name: "Electromedical Technologies, Inc"
filed_at: "2022-09-23T23:59:59+00:00"
generated_at: "2026-06-23T07:47:23.173969+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CEO receives super-voting preferred shares, now controls 75.48% of voting power

## Summary
- Issued 500,000 Series A Preferred shares to CEO Matthew Wolfson as retention consideration; each share carries 100 votes.
- Wolfson now holds 1M Series A Preferred and 15.4M common shares, representing 75.48% of total voting power.
- Board increased authorized shares to 999M common, 1M Series A Preferred, and 1 Series B Preferred, approved by written consent.
- Wolfson committed to remain as PEO and PFO while employment agreement amendments are finalized.

## SEC filing metadata
- accession: 0001104659-22-102659
- form_type: 8-K
- ticker: EMED
- cik: 0001715819
- company_name: Electromedical Technologies, Inc
- filed_at: 2022-09-23T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.02, 5.01, 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1715819/000110465922102659/0001104659-22-102659-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1715819/000110465922102659/tm2226564d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-102659
- JSON: https://secwatch.observer/filing/0001104659-22-102659.json
- Plain text: https://secwatch.observer/filing/0001104659-22-102659.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.